01 1Raks Pharma
01 1RIVAROXABAN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-04-28
Pay. Date : 2015-02-16
DMF Number : 29066
Submission : 2015-03-18
Status : Active
Type : II
20
Raks Pharma Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and WHO-GMP.
One of their notable products is RIVAROXABAN, with a corresponding US DMF Number 29066.
Remarkably, this DMF maintains an Active status since its submission on March 18, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 28, 2015, and payment made on February 16, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II
